NDC 64661-650

EnBrace HR

Levomefolate Magnesium, Leucovorin, Folic Acid, Ferrous Cysteine Glycinate, Magnesium Ascorbate, Zinc Ascorbate, Cocarboxylase, Flavin Adenine Dinucleotide, Nadh, Pyridoxal Phosphate Anhydrous, Cobamamide, Betaine, Magnesium L-threonate, 1,2-docosahexanoyl-sn-glycero-3-phosphoserine Calcium, 1,2-icosapentoyl-sn-glycero-3-phosphoserine Calcium, And Phosphatidyl Serine

EnBrace HR is a Oral Capsule, Delayed Release Pellets in the Human Prescription Drug category. It is labeled and distributed by Jaymac Pharma. The primary component is 1,2-docosahexanoyl-sn-glycero-3-phosphoserine Calcium; 1,2-icosapentoyl-sn-glycero-3-phosphoserine Calcium; Betaine; Cobamamide; Cocarboxylase; Ferrous Cysteine Glycinate; Flavin Adenine Dinucleotide; Folic Acid; Leucovorin; Levomefolate Magnesium; Magnesium Ascorbate; Magnesium L-threonate; Nadh; Phosphatidyl Serine; Pyridoxal Phosphate Anhydrous; Zinc Ascorbate.

Product ID64661-650_1251bc0d-1b8b-4597-a23a-c94dab3b1fb5
NDC64661-650
Product TypeHuman Prescription Drug
Proprietary NameEnBrace HR
Generic NameLevomefolate Magnesium, Leucovorin, Folic Acid, Ferrous Cysteine Glycinate, Magnesium Ascorbate, Zinc Ascorbate, Cocarboxylase, Flavin Adenine Dinucleotide, Nadh, Pyridoxal Phosphate Anhydrous, Cobamamide, Betaine, Magnesium L-threonate, 1,2-docosahexanoyl-sn-glycero-3-phosphoserine Calcium, 1,2-icosapentoyl-sn-glycero-3-phosphoserine Calcium, And Phosphatidyl Serine
Dosage FormCapsule, Delayed Release Pellets
Route of AdministrationORAL
Marketing Start Date2011-08-12
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameJaymac Pharma
Substance Name1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; BETAINE; COBAMAMIDE; COCARBOXYLASE; FERROUS CYSTEINE GLYCINATE; FLAVIN ADENINE DINUCLEOTIDE; FOLIC ACID; LEUCOVORIN; LEVOMEFOLATE MAGNESIUM; MAGNESIUM ASCORBATE; MAGNESIUM L-THREONATE; NADH; PHOSPHATIDYL SERINE; PYRIDOXAL PHOSPHATE ANHYDROUS; ZINC ASCORBATE
Active Ingredient Strength6 mg/1; ug/1; ug/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1
Pharm ClassesAscorbic Acid [CS], Ascorbic Acid [CS], Folate Analog [EPC], Folic Acid [CS], Methylating Activity [MoA], Methylating Agent [EPC], Vitamin C [EPC], Vitamin C [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 64661-650-30

30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (64661-650-30)
Marketing Start Date2011-08-12
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64661-650-30 [64661065030]

EnBrace HR CAPSULE, DELAYED RELEASE PELLETS
Marketing CategoryUNAPPROVED DRUG OTHER
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-08-12

Drug Details

Active Ingredients

IngredientStrength
LEVOMEFOLATE MAGNESIUM5.23 mg/1

OpenFDA Data

SPL SET ID:6f14fa40-97ab-4ec5-b66b-793d6d1abac9
Manufacturer
UNII
PHarm Class EPC
  • Folate Analog [EPC]
  • UPC Code
  • 0364661650302
  • NUI Code
  • N0000178369
  • N0000175452
  • N0000007151
  • Pharmacological Class

    • Folate Analog [EPC]
    • Folic Acid [Chemical/Ingredient]
    • Analogs/Derivatives [Chemical/Ingredient]
    • Vitamin C [EPC]
    • Ascorbic Acid [CS]
    • Vitamin C [EPC]
    • Ascorbic Acid [CS]
    • Methylating Activity [MoA]
    • Methylating Agent [EPC]

    Trademark Results [EnBrace HR]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ENBRACE HR
    ENBRACE HR
    86691000 4939954 Live/Registered
    Jaymac Pharmaceuticals, LLC
    2015-07-13

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.